Neuroscience Bulletin

, Volume 29, Issue 4, pp 445–459 | Cite as

Biomaterials for spinal cord repair



Spinal cord injury (SCI) results in permanent loss of function leading to often devastating personal, economic and social problems. A contributing factor to the permanence of SCI is that damaged axons do not regenerate, which prevents the re-establishment of axonal circuits involved in function. Many groups are working to develop treatments that address the lack of axon regeneration after SCI. The emergence of biomaterials for regeneration and increased collaboration between engineers, basic and translational scientists, and clinicians hold promise for the development of effective therapies for SCI. A plethora of biomaterials is available and has been tested in various models of SCI. Considering the clinical relevance of contusion injuries, we primarily focus on polymers that meet the specific criteria for addressing this type of injury. Biomaterials may provide structural support and/or serve as a delivery vehicle for factors to arrest growth inhibition and promote axonal growth. Designing materials to address the specific needs of the damaged central nervous system is crucial and possible with current technology. Here, we review the most prominent materials, their optimal characteristics, and their potential roles in repairing and regenerating damaged axons following SCi.


spinal cord injury axon regeneration biodegradable materials extracellular matrix proteins functional recovery growth factor guidance injury and repair spinal motor neuron 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    One Degree of Separation: Paralysis and Spinal Cord injury in the United States. Christopher & Dana Reeve Foundation, 2010.Google Scholar
  2. [2]
    Cao HQ, Dong ED. An update on spinal cord injury research. Neurosci Bull 2013, 29: 94–102.PubMedCrossRefGoogle Scholar
  3. [3]
    Ramon Y Cajal S. Degeneration and Regeneration of the Nervous System. London: Oxford University Press, 1928.Google Scholar
  4. [4]
    von Euler M, Janson AM, Larsen JO, Seiger A, Forno L, Bunge MB, et al. Spontaneous axonal regeneration in rodent spinal cord after ischemic injury. J Neuropathol Exp Neurol 2002, 61: 64–75.Google Scholar
  5. [5]
    Bunge MB. Bridging areas of injury in the spinal cord. Neuroscientist 2001, 7: 325–339.PubMedCrossRefGoogle Scholar
  6. [6]
    Jenkins AD, Kratochvil P, Stepto RFT, Suter UW. Glossary of basic terms in polymer science. Pure Appl Chem 1996, 68: 2287–2311.CrossRefGoogle Scholar
  7. [7]
    Ratner BD, Lemons J, Schoen F, Hoffman AS. Biomaterials Science: An introduction to Materials in Medicine. 2nd ed. San Diego: Academic Press, 2004.Google Scholar
  8. [8]
    Williams DF. On the mechanisms of biocompatibility. Biomaterials 2008, 29: 2941–2953.PubMedCrossRefGoogle Scholar
  9. [9]
    Hiemstra C, Aa LJ, Zhong Z, Dijkstra PJ, Feijen J. Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition. Biomacromolecules 2007, 8: 1548–1556.PubMedCrossRefGoogle Scholar
  10. [10]
    Hiemstra C, Zhou W, Zhong Z, Wouters M, Feijen J. Rapidly in situ forming biodegradable robust hydrogels by combining stereocomplexation and photopolymerization. J Am Chem Soc 2007, 129: 9918–9926.PubMedCrossRefGoogle Scholar
  11. [11]
    Jain A, Kim YT, McKeon RJ, Bellamkonda RV. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials 2006, 27: 497–504.PubMedCrossRefGoogle Scholar
  12. [12]
    Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA. Hydrogels in regenerative medicine. Adv Mater 2009, 21: 3307–3329.PubMedCrossRefGoogle Scholar
  13. [13]
    Sanes JR. Extracellular matrix molecules that influence neural development. Annu Rev Neurosci 1989, 12: 491–516.PubMedCrossRefGoogle Scholar
  14. [14]
    Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and their receptors: functions in neural development. Annu Rev Neurosci 1991, 14: 531–570.PubMedCrossRefGoogle Scholar
  15. [15]
    Calof AL, Lander AD. Relationship between neuronal migration and cell-substratum adhesion: laminin and merosin promote olfactory neuronal migration but are anti-adhesive. J Cell Biol 1991, 115: 779–794.PubMedCrossRefGoogle Scholar
  16. [16]
    Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr opin Neurobiol 2007, 17: 120–127.PubMedCrossRefGoogle Scholar
  17. [17]
    Tomaselli KJ. Beta 1-integrin-mediated neuronal responses to extracellular matrix proteins. Ann N Y Acad Sci 1991, 633: 100–104.PubMedCrossRefGoogle Scholar
  18. [18]
    Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996, 12: 697–715.PubMedCrossRefGoogle Scholar
  19. [19]
    Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002, 13: 377–383.PubMedCrossRefGoogle Scholar
  20. [20]
    Evans CH, Drouven BJ. The promotion of collagen polymerization by lanthanide and calcium ions. Biochem J 1983, 213: 751–758.PubMedGoogle Scholar
  21. [21]
    Di Lullo G, Sweeney S, Korkko J, Ala-Kokko L, San Antonio J. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 2002, 277: 4223–4231.PubMedCrossRefGoogle Scholar
  22. [22]
    Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. Biochemistry 1984, 23: 1839–1850.PubMedCrossRefGoogle Scholar
  23. [23]
    Wood GC. The formation of fibrils from collagen solutions. 3. Effect of chondroitin sulphate and some other naturally occurring polyanions on the rate of formation. Biochem J 1960, 75: 605–612.PubMedGoogle Scholar
  24. [24]
    Wood GC. The formation of fibrils from collagen solutions. 2. A mechanism of collagen-fibril formation. Biochem J 1960, 75: 598–605.PubMedGoogle Scholar
  25. [25]
    Wood GC, Keech MK. The formation of fibrils from collagen solutions. 1. The effect of experimental conditions: kinetic and electron-microscope studies. Biochem J 1960, 75: 588–598.PubMedGoogle Scholar
  26. [26]
    Sung KE, Su G, Pehlke C, Trier SM, Eliceiri KW, Keely PJ, et al. Control of 3-dimensional collagen matrix polymerization for reproducible human mammary fibroblast cell culture in microfluidic devices. Biomaterials 2009, 30: 4833–4841.PubMedCrossRefGoogle Scholar
  27. [27]
    Velegol D, Lanni F. Cell traction forces on soft biomaterials. I. Microrheology of type I collagen gels. Biophysi J 2001, 81: 1786–1792.CrossRefGoogle Scholar
  28. [28]
    Marriott RH. The swelling of single collagen fibre-bundles. Biochem J 1932, 26: 46–53.PubMedGoogle Scholar
  29. [29]
    Jokinen J, Dadu E, Nykvist P, Kapyla J, White DJ, Ivaska J, et al. Integrin-mediated cell adhesion to type I collagen fibrils. J Biol Chem 2004, 279: 31956–31963.PubMedCrossRefGoogle Scholar
  30. [30]
    Vogel WF. Collagen-receptor signaling in health and disease. Eur J Dermatol 2001, 11: 506–514.PubMedGoogle Scholar
  31. [31]
    Cholas R, Hsu HP, Spector M. Collagen scaffolds incorporating select therapeutic agents to facilitate a reparative response in a standardized hemiresection defect in the rat spinal cord. Tissue Eng Part A 2012, 18: 2158–2172.PubMedCrossRefGoogle Scholar
  32. [32]
    Cholas RH, Hsu HP, Spector M. The reparative response to cross-linked collagen-based scaffolds in a rat spinal cord gap model. Biomaterials 2012, 33: 2050–2059.PubMedCrossRefGoogle Scholar
  33. [33]
    Dubey N, Letourneau PC, Tranquillo RT. Guided neurite elongation and schwann cell invasion into magnetically aligned collagen in simulated peripheral nerve regeneration. Exp Neurol 1999, 158: 338–350.PubMedCrossRefGoogle Scholar
  34. [34]
    Ceballos D, Navarro X, Dubey N, Wendelschafer-Crabb G, Kennedy WR, Tranquillo RT. Magnetically aligned collagen gel filling a collagen nerve guide improves peripheral nerve regeneration. Exp Neurol 1999, 158: 290–300.PubMedCrossRefGoogle Scholar
  35. [35]
    Verdu E, Labrador Ro, Rodriguez FJ, Ceballos D, Fores J, Navarro X. Alignment of collagen and laminin-containing gels improve nerve regeneration within silicone tubes. Restor Neurol Neurosci 2002, 20: 169–179.PubMedGoogle Scholar
  36. [36]
    Torbet J, Malbouyres M, Builles N, Justin V, Roulet M, Damour O, et al. Orthogonal scaffold of magnetically aligned collagen lamellae for corneal stroma reconstruction. Biomaterials 2007, 28: 4268–4276.PubMedCrossRefGoogle Scholar
  37. [37]
    Ma W, Fitzgerald W, Liu QY, O’Shaughnessy T, Maric D, Lin H, et al. CNS stem and progenitor cell differentiation into functinoal neuronal circuits in three-dimensional collagen gels. Exp Neurol 2004, 190: 276–288.PubMedCrossRefGoogle Scholar
  38. [38]
    Hatami M, Mehrjardi NZ, Kiani S, Hemmesi K, Azizi H, Shahverdi A, et al. Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy 2009, 11: 618–630.PubMedCrossRefGoogle Scholar
  39. [39]
    Labrador Ro, Buti M, Navarro X. Influence of collagen and laminin gels concentration on nerve regeneration after resection and tube repair. Exp Neurol 1998, 149: 243–252.PubMedCrossRefGoogle Scholar
  40. [40]
    Yoshii S, Oka M, Shima M, Akagi M, Taniguchi A. Bridging a spinal cord defect using collagen filament. Spine (Phila Pa 1976) 2003, 28: 2346–2351.Google Scholar
  41. [41]
    Colognato H, Winkelmann D, Yurchenco P. Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 1999, 145: 619–631.PubMedCrossRefGoogle Scholar
  42. [42]
    Freire E, Gomes F, Linden R, Neto V, Coelho-Sampaio T. Structure of laminin substrates modulates cellular signaling for neuritogenesis. J Cell Sci 2002, 115: 4867–4876.PubMedCrossRefGoogle Scholar
  43. [43]
    Tomaselli K, Hall D, Flier L, Gehlsen K, Turner D, Carbonetto S, et al. A neuronal cell line (PC12) expresses two b1 class integrins a1b1 and a3b1-that recognize different neurite outgrowth-promoting domains in laminin. Neuron 1990, 5: 651–662.PubMedCrossRefGoogle Scholar
  44. [44]
    Cornbrooks CJ, Carey DJ, McDonald JA, Timpl R, Bunge RP. In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci U S A 1983, 80: 3850–3854.PubMedCrossRefGoogle Scholar
  45. [45]
    Plantman S, Patarroyo M, Fried K, Domogatskaya A, Tryggvason K, Hammarberg H, et al. Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. Mol Cell Neurosci 2008, 39: 50–62.PubMedCrossRefGoogle Scholar
  46. [46]
    Liesi P. Do neurons in the vertebrate CNS migrate on laminin? EMBo J 1985, 4: 1163–1170.PubMedGoogle Scholar
  47. [47]
    Liesi P. Laminin-immoreactive glia distinguish regenerative adult CNS systems from non-regenerative ones. EMBo J 1985, 4: 2505–2511.PubMedGoogle Scholar
  48. [48]
    Tate C, Shear D, Tate M, Archer D, Stein D, LaPlaca M. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Regen Med Tissue Eng 2009, 3: 208–217.CrossRefGoogle Scholar
  49. [49]
    Menezes K, Lacerda de Menezes J, Nascimento M, de Siqueira Santos R, Coelho-Sampaio T. Polylaminin, a polymeric form of laminin, promotes regeneration after spinal cord injury. FASEB J 2010, 24(11): 4513–4522.PubMedCrossRefGoogle Scholar
  50. [50]
    Colognato H, Yurchenco P. Form and function: the laminin family of heterotrimers. Dev Dyn 2000, 218: 213–234.PubMedCrossRefGoogle Scholar
  51. [51]
    Mruthyunjaya S, Manchanda R, Godbole R, Pujari R, Shiras A, Shastry P. Laminin-1 induces neurite outgrowth in human mesenchymal stem cells in serum/differentiation factors-free conditions through activation of FAK-MEK/ERK signaling pathways. Biochem Biophys Res Commun 2010, 391: 43–48.PubMedCrossRefGoogle Scholar
  52. [52]
    Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005, 15: 378–386.PubMedCrossRefGoogle Scholar
  53. [53]
    Tsai EC, Dalton PD, Shoichet MS, Tator CH. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials 2006, 27: 519–533.PubMedCrossRefGoogle Scholar
  54. [54]
    Tate MC, Garcia AJ, Keselowsky BG, Schumm MA, Archer DR, LaPlaca MC. Specific beta1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol Cell Neurosci 2004, 27: 22–31.PubMedCrossRefGoogle Scholar
  55. [55]
    Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999, 285: 1028–1032.PubMedCrossRefGoogle Scholar
  56. [56]
    Hodde J, Record R, Tullius R, Badylak S. Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. Biomaterials 2002, 23: 1841–1848.PubMedCrossRefGoogle Scholar
  57. [57]
    Bozyczko D, Horwitz A. The participation of putative cell surface receptor for laminin and fibronectin in peripheral neurite extension. J Neurosci 1986, 6(5): 1241–1251.PubMedGoogle Scholar
  58. [58]
    Magnusson MK, Mosher DF. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998, 18: 1363–1370.PubMedCrossRefGoogle Scholar
  59. [59]
    Miyamoto S, Katz BZ, Lafrenie RM, Yamada KM. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann N Y Acad Sci 1998, 857: 119–129.PubMedCrossRefGoogle Scholar
  60. [60]
    Aota S, Nomizu M, Yamada KM. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 1994, 269: 24756–24761.PubMedGoogle Scholar
  61. [61]
    Redick SD, Settles DL, Briscoe G, Erickson HP. Defining fibronectin’s cell adhesion synergy site by site-directed mutagenesis. J Cell Biol 2000, 149: 521–527.PubMedCrossRefGoogle Scholar
  62. [62]
    Novikov LN, Novikova LN, Mosahebi A, Wiberg M, Terenghi G, Kellerth JO. A novel biodegradable implant for neuronal rescue and regeneration after spinal cord injury. Biomaterials 2002, 23: 3369–3376.PubMedCrossRefGoogle Scholar
  63. [63]
    Oudega M. Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair. Cell Tissue Res 2012, 349: 269–288.PubMedCrossRefGoogle Scholar
  64. [64]
    Novikova LN, Novikov LN, Kellerth JO. Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury. Curr opin Neurol 2003, 16: 711–715.PubMedCrossRefGoogle Scholar
  65. [65]
    Bignami A, Hosley M, Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol (Berl) 1993, 188: 419–433.CrossRefGoogle Scholar
  66. [66]
    Cui FZ, Tian WM, Hou SP, Xu QY, Lee IS. Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering. J Mater Sci Mater Med 2006, 17: 1393–1401.PubMedCrossRefGoogle Scholar
  67. [67]
    Fuqua J, Stokols D, Gress J, Phillips K, Harvey R. Transdisciplinary collaboration as a basis for enhancing the science and prevention of Substance use and “Abuse”. Subst Use Misuse 2004, 39: 1457–1514.PubMedCrossRefGoogle Scholar
  68. [68]
    Caicco MJ, Zahir T, Mothe AJ, Ballios BG, Kihm AJ, Tator CH, et al. Characterization of hyaluronan-methylcellulose hydrogels for cell delivery to the injured spinal cord. J Biomed Mater Res A 2013, 101(5): 1472–1477.PubMedGoogle Scholar
  69. [69]
    Leach JB, Bivens KA, Patrick CW, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003, 82: 578–589.CrossRefGoogle Scholar
  70. [70]
    Austin JW, Kang CE, Baumann MD, DiDiodato L, Satkunendrarajah K, Wilson JR, et al. The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis. Biomaterials 2012, 33: 4555–4564.PubMedCrossRefGoogle Scholar
  71. [71]
    Park J, Lim E, Back S, Na H, Park Y, Sun K. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J Biomed Mater Res A 2010, 93: 1091–1099.PubMedGoogle Scholar
  72. [72]
    Horn EM, Beaumont M, Shu XZ, Harvey A, Prestwich GD, Horn KM, et al. Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth and recovery from spinal cord injury. J Neurosurg Spine 2007, 6: 133–140.PubMedCrossRefGoogle Scholar
  73. [73]
    Halfter W, Reckhaus W, Kroger S. Nondirected axonal growth on basal lamina from avian embryonic neural retina. J Neurosci 1987, 7: 3712–3722.PubMedGoogle Scholar
  74. [74]
    Davis GE, Blaker SN, Engvall E, Varon S, Manthorpe M, Gage FH. Human amnion membrane serves as a substratum for growing axons in vitro and in vivo. Science 1987, 236: 1106–1109.PubMedCrossRefGoogle Scholar
  75. [75]
    Halfter W, Candiello J, Hu H, Zhang P, Schreiber E, Balasubramani M. Protein composition and biomechanical properties of in vivo-derived basement membranes. Cell Adh Migr 2013, 7: 64–71.PubMedCrossRefGoogle Scholar
  76. [76]
    Bunge MB, Bunge RP, Kleitman N, Dean AC. Role of peripheral nerve extracellular matrix in Schwann cell function and in neurite regeneration. Dev Neurosci 1989, 11: 348–360.PubMedCrossRefGoogle Scholar
  77. [77]
    Gilbert TW, Freund JM, Badylak SF. Quantification of DNA in biologic scaffold materials. J Surg Res 2009, 152: 135–139.PubMedCrossRefGoogle Scholar
  78. [78]
    Badylak S, Arnoczky S, Plouhar P, Haut R, Mendenhall V, Clarke R, et al. Naturally occurring extracellular matrix as a scaffold for musculoskeletal repair. Clin orthop Relat Res 1999, 367: S333–343.PubMedCrossRefGoogle Scholar
  79. [79]
    Gilbert TW, Stolz DB, Biancaniello F, Simmons-Byrd A, Badylak SF. Production and characterization of ECM powder: implications for tissue engineering applications. Biomaterials 2005, 26: 1431–1435.PubMedCrossRefGoogle Scholar
  80. [80]
    Medberry CJ, Crapo PM, Siu BF, Carruthers CA, Wolf MT, Nagarkar SP, et al. Hydrogels derived from central nervous system extracellular matrix. Biomaterials 2013, 34: 1033–1040.PubMedCrossRefGoogle Scholar
  81. [81]
    Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25: 1015–1024.PubMedCrossRefGoogle Scholar
  82. [82]
    Xu XM, Chen A, Guenard V, Kleitman N, Bunge MB. Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J Neurocytol 1997, 26: 1–16.PubMedCrossRefGoogle Scholar
  83. [83]
    Xu XM, Guenard V, Kleitman N, Bunge MB. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol 1995, 351: 145–160.PubMedCrossRefGoogle Scholar
  84. [84]
    Badylak SF, Vorp DA, Spievack AR, Simmons-Byrd A, Hanke J, Freytes DO, et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res 2005, 128: 87–97.PubMedCrossRefGoogle Scholar
  85. [85]
    Liu J, Chen J, Liu B, Yang C, Xie D, Zheng X, et al. Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats. J Neurol Sci 2013, 325: 127–136.PubMedCrossRefGoogle Scholar
  86. [86]
    Wrathall JR, Pettegrew RK, Harvey F. Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp Neurol 1985, 88: 108–122.PubMedCrossRefGoogle Scholar
  87. [87]
    Li X, Xiao Z, Han J, Chen L, Xiao H, Ma F, et al. Promotion of neuronal differentiation of neural progenitor cells by using EGFR antibody functionalized collagen scaffolds for spinal cord injury repair. Biomaterials 2013, 34: 5107–5116.PubMedCrossRefGoogle Scholar
  88. [88]
    Cheng H, Huang YC, Chang PT, Huang YY. Lamininincorporated nerve conduits made by plasma treatment for repairing spinal cord injury. Biochem Biophys Res Commun 2007, 357: 938–944.PubMedCrossRefGoogle Scholar
  89. [89]
    Lin CY, Lee YS, Lin VW, Silver J. Fibronectin inhibits chronic pain development after spinal cord injury. J Neurotrauma 2012, 29: 589–599.PubMedCrossRefGoogle Scholar
  90. [90]
    King VR, Alovskaya A, Wei DY, Brown RA, Priestley JV. The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury. Biomaterials 2010, 31: 4447–4456.PubMedCrossRefGoogle Scholar
  91. [91]
    King VR, Hewazy D, Alovskaya A, Phillips JB, Brown RA, Priestley JV. The neuroprotective effects of fibronectin mats and fibronectin peptides following spinal cord injury in the rat. Neuroscience 2010, 168: 523–530.PubMedCrossRefGoogle Scholar
  92. [92]
    Baumann MD, Kang CE, Tator CH, Shoichet MS. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury. Biomaterials 2010, 31: 7631–7639.PubMedCrossRefGoogle Scholar
  93. [93]
    Khaing ZZ, Milman BD, Vanscoy JE, Seidlits SK, Grill RJ, Schmidt CE. High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury. J Neural Eng 2011, 8: 046033.PubMedCrossRefGoogle Scholar
  94. [94]
    Li C, Zhang X, Cao R, Yu B, Liang H, Zhou M, et al. Allografts of the acellular sciatic nerve and brain-derived neurotrophic factor repair spinal cord injury in adult rats. PLoS one 2012, 7: e42813.PubMedCrossRefGoogle Scholar
  95. [95]
    Xue H, Zhang XY, Liu JM, Song Y, Li YF, Chen D. Development of a chemically extracted acellular muscle scaffold seeded with amniotic epithelial cells to promote spinal cord repair. J Biomed Mater Res A 2013, 101: 145–156.PubMedGoogle Scholar
  96. [96]
    Bozkurt G, Mothe AJ, Zahir T, Kim H, Shoichet MS, Tator CH. Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat. Neurosurgery 2010, 67: 1733–1744.PubMedCrossRefGoogle Scholar
  97. [97]
    Haipeng G, Yinghui Z, Jianchun L, Yandao G, Nanming Z, Xiufang Z. Studies on nerve cell affinity of chitosan-derived materials. J Biomed Mater Res 2000, 52: 285–295.PubMedCrossRefGoogle Scholar
  98. [98]
    Nomura H, Baladie B, Katayama Y, Morshead CM, Shoichet MS, Tator CH. Delayed implantation of intramedullary chitosan channels containing nerve grafts promotes extensive axonal regeneration after spinal cord injury. Neurosurgery 2008, 63: 127–141; discussion 141–123.PubMedCrossRefGoogle Scholar
  99. [99]
    Peluso G, Petillo O, Ranieri M, Santin M, Ambrosio L, Calabro D, et al. Chitosan-mediated stimulation of macrophage function. Biomaterials 1994, 15: 1215–1220.PubMedCrossRefGoogle Scholar
  100. [100]
    Crompton KE, Tomas D, Finkelstein Di, Marr M, Forsythe JS, Horne MK. Inflammatory response on injection of chitosan/GP to the brain. J Mater Sci Mater Med 2006, 17: 633–639.PubMedCrossRefGoogle Scholar
  101. [101]
    Varum KM, Myhr MM, Hjerde RJ, Smidsrod O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr Res 1997, 299: 99–101.PubMedCrossRefGoogle Scholar
  102. [102]
    Lim SM, Song DK, Oh SH, Lee-Yoon DS, Bae EH, Lee JH. In vitro and in vivo degradation behavior of acetylated chitosan porous beads. J Biomater Sci Polym Ed 2008, 19: 453–466.PubMedCrossRefGoogle Scholar
  103. [103]
    Pangburn SH, Trescony PV, Heller J. Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials 1982, 3: 105–108.PubMedCrossRefGoogle Scholar
  104. [104]
    Luo Y, Shoichet MS. A photolabile hydrogel for guided threedimensional cell growth and migration. Nat Mater 2004, 3: 249–253.PubMedCrossRefGoogle Scholar
  105. [105]
    Bellamkonda R, Ranieri JP, Bouche N, Aebischer P. Hydrogel-based three-dimensional matrix for neural cells. J Biomed Mater Res 1995, 29: 663–671.PubMedCrossRefGoogle Scholar
  106. [106]
    Stokols S, Tuszynski MH. The fabrication and characterization of linearly oriented nerve guidance scaffolds for spinal cord injury. Biomaterials 2004, 25: 5839–5846.PubMedCrossRefGoogle Scholar
  107. [107]
    Zhang B, Wang Y, Gao M, Gu M, Wang C. Tr i s (hydroxymethyl)aminomethane-functionalized agarose particles: parameters affecting the binding of bovine serum albumin. J Sep Sci 2012, 35: 1406–1410.PubMedCrossRefGoogle Scholar
  108. [108]
    Matyash M, Despang F, Mandal R, Fiore D, Gelinsky M, Ikonomidou C. Novel soft alginate hydrogel strongly supports neurite growth and protects neurons against oxidative stress. Tissue Eng Part A 2012, 18: 55–66.PubMedCrossRefGoogle Scholar
  109. [109]
    Dillon GP, Yu X, Sridharan A, Ranieri JP, Bellamkonda RV. The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Ed 1998, 9: 1049–1069.PubMedCrossRefGoogle Scholar
  110. [110]
    Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20: 45–53.PubMedCrossRefGoogle Scholar
  111. [111]
    Nisbet DR, Crompton KE, Horne MK, Finkelstein DI, Forsythe JS. Neural tissue engineering of the CNS using hydrogels. J Biomed Mater Res B Appl Biomater 2008, 87: 251–263.PubMedGoogle Scholar
  112. [112]
    Nisbet DR, Rodda AE, Horne MK, Forsythe JS, Finkelstein DI. Implantation of functionalized thermally gelling xyloglucan hydrogel within the brain: associated neurite infiltration and inflammatory response. Tissue Eng Part A 2010, 16: 2833–2842.PubMedCrossRefGoogle Scholar
  113. [113]
    Oliveira AL, Sousa EC, Silva NA, Sousa N, Salgado AJ, Reis RL. Peripheral mineralization of a 3D biodegradable tubular construct as a way to enhance guidance stabilization in spinal cord injury regeneration. J Mater Sci Mater Med 2012, 23: 2821–2830.PubMedCrossRefGoogle Scholar
  114. [114]
    Dalton PD, Flynn L, Shoichet MS. Manufacture of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel tubes for use as nerve guidance channels. Biomaterials 2002, 23: 3843–3851.PubMedCrossRefGoogle Scholar
  115. [115]
    Belkas JS, Munro CA, Shoichet MS, Johnston M, Midha R. Long-term in vivo biomechanical properties and biocompatibility of poly(2-hydroxyethyl methacrylate-comethyl methacrylate) nerve conduits. Biomaterials 2005, 26: 1741–1749.PubMedCrossRefGoogle Scholar
  116. [116]
    Woerly S, Pinet E, de Robertis L, Van Diep D, Bousmina M. Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). Biomaterials 2001, 22: 1095–1111.PubMedCrossRefGoogle Scholar
  117. [117]
    Lesny P, De Croos J, Pradny M, Vacik J, Michalek J, Woerly S, et al. Polymer hydrogels usable for nervous tissue repair. J Chem Neuroanat 2002, 23: 243–247.PubMedCrossRefGoogle Scholar
  118. [118]
    Park D, Wu W, Wang Y. A functionalizable reverse thermal gel based on polyurethane/PEG block copolymer. Biomaterials 2011, 32: 777–786.PubMedCrossRefGoogle Scholar
  119. [119]
    Borgens RB, Shi R. Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J 2000, 14: 27–35.PubMedGoogle Scholar
  120. [120]
    Shi R, Borgens RB. Anatomical repair of nerve membranes in crushed mammalian spinal cord with polyethylene glycol. J Neurocytol 2000, 29: 633–643.PubMedCrossRefGoogle Scholar
  121. [121]
    Shi R, Borgens RB. Acute repair of crushed guinea pig spinal cord by polyethylene glycol. J Neurophysiol 1999, 81: 2406–2414.PubMedGoogle Scholar
  122. [122]
    Shi R, Borgens RB, Blight AR. Functional reconnection of severed mammalian spinal cord axons with polyethylene glycol. J Neurotrauma 1999, 16: 727–738.PubMedCrossRefGoogle Scholar
  123. [123]
    Borgens RB, Shi R, Bohnert D. Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol. J Exp Biol 2002, 205: 1–12.PubMedGoogle Scholar
  124. [124]
    Borgens RB, Bohnert D. Rapid recovery from spinal cord injury after subcutaneously administered polyethylene glycol. J Neurosci Res 2001, 66: 1179–1186.PubMedCrossRefGoogle Scholar
  125. [125]
    Mann BK, Gobin AS, Tsai AT, Schmedlen RH, West JL. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 2001, 22: 3045–3051.PubMedCrossRefGoogle Scholar
  126. [126]
    Park D, Wu W, Wang Y. A functionalizable reverse thermal gel based on a polyurethane/PEG block copolymer. Biomaterials 2011, 32: 777–786.PubMedCrossRefGoogle Scholar
  127. [127]
    Chen N, Zhang Z, Soontornworajit B, Zhou J, Wang Y. Cell adhesion on an artificial extracellular matrix using aptamerfunctionalized PEG hydrogels. Biomaterials 2012, 33: 1353–1362.PubMedCrossRefGoogle Scholar
  128. [128]
    Lin CC, Anseth KS. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 2009, 26: 631–643.PubMedCrossRefGoogle Scholar
  129. [129]
    Luo J, Borgens R, Shi R. Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J Neurochem 2002, 83: 471–480.PubMedCrossRefGoogle Scholar
  130. [130]
    Luo J, Borgens R, Shi R. Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J Neurotrauma 2004, 21: 994–1007.PubMedCrossRefGoogle Scholar
  131. [131]
    Royce Hynes S, McGregor LM, Ford Rauch M, Lavik EB. Photopolymerized poly(ethylene glycol)/poly(L-lysine) hydrogels for the delivery of neural progenitor cells. J Biomater Sci Polym Ed 2007, 18: 1017–1030.PubMedCrossRefGoogle Scholar
  132. [132]
    Chiellini E, Corti A, D’Antone S, Solaro R. Biodegradation of poly (vinyl alcohol) based materials. Prog Polym Sci 2003, 28: 963–1014.CrossRefGoogle Scholar
  133. [133]
    Chvatal SA, Kim YT, Bratt-Leal AM, Lee H, Bellamkonda RV. Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials 2008, 29: 1967–1975.PubMedCrossRefGoogle Scholar
  134. [134]
    Comolli N, Donaldson O, Grantier N, Zhukareva V, Tom VJ. Polyvinyl alcohol-polyvinyl pyrrolidone thin films provide local short-term release of anti-inflammatory agents post spinal cord injury. J Biomed Mater Res B Appl Biomater 2012, 100B: 1867–1873.CrossRefGoogle Scholar
  135. [135]
    Chen BK, Knight AM, de Ruiter GC, Spinner RJ, Yaszemski MJ, Currier BL, et al. Axon regeneration through scaffold into distal spinal cord after transection. J Neurotrauma 2009, 26: 1759–1771.PubMedCrossRefGoogle Scholar
  136. [136]
    Straley KS, Foo CW, Heilshorn SC. Biomaterial design strategies for the treatment of spinal cord injuries. J Neurotrauma 2010, 27: 1–19.PubMedCrossRefGoogle Scholar
  137. [137]
    Patist CM, Mulder MB, Gautier SE, Maquet V, Jerome R, Oudega M. Freeze-dried poly(D,L-lactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials 2004, 25: 1569–1582.PubMedCrossRefGoogle Scholar
  138. [138]
    Gautier SE, Oudega M, Fragoso M, Chapon P, Plant GW, Bunge MB, et al. Poly(alpha-hydroxyacids) for application in the spinal cord: resorbability and biocompatibility with adult rat Schwann cells and spinal cord. J Biomed Mater Res 1998, 42: 642–654.PubMedCrossRefGoogle Scholar
  139. [139]
    Oudega M, Gautier SE, Chapon P, Fragoso M, Bates ML, Parel JM, et al. Axonal regeneration into Schwann cell grafts within resorbable poly(alpha-hydroxyacid) guidance channels in the adult rat spinal cord. Biomaterials 2001, 22: 1125–1136.PubMedCrossRefGoogle Scholar
  140. [140]
    Hejcl A, Urdzikova L, Sedy J, Lesny P, Pradny M, Michalek J, et al. Acute and delayed implantation of positively charged 2-hydroxyethyl methacrylate scaffolds in spinal cord injury in the rat. J Neurosurg Spine 2008, 8: 67–73.PubMedCrossRefGoogle Scholar
  141. [141]
    Bakshi A, Fisher O, Dagci T, Himes BT, Fischer I, Lowman A. Mechanically engineered hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord injury. J Neurosurg Spine 2004, 1: 322–329.PubMedCrossRefGoogle Scholar
  142. [142]
    Woerly S, Doan VD, Sosa N, de Vellis J, Espinosa-Jeffrey A. Prevention of gliotic scar formation by NeuroGel allows partial endogenous repair of transected cat spinal cord. J Neurosci Res 2004, 75: 262–272.PubMedCrossRefGoogle Scholar
  143. [143]
    Luo J, Shi R. Polyethylene glycol inhibits apoptotic cell death following traumatic spinal cord injury. Brain Res 2007, 1155: 10–16.PubMedCrossRefGoogle Scholar
  144. [144]
    Hiraizumi Y, Transfeldt EE, Fujimaki E, Nambu M. Application of polyvinyl alcohol hydrogel membrane as anti-adhesive interposition after spinal surgery. Spine (Phila Pa 1976) 1995, 20: 2272–2277.Google Scholar
  145. [145]
    Teng YD, Lavik EB, Qu X, Park Ki, Ourednik J, Zurakowski D, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 2002, 99: 3024–3029.PubMedCrossRefGoogle Scholar
  146. [146]
    Kim YT, Caldwell JM, Bellamkonda RV. Nanoparticlemediated local delivery of Methylprednisolone after spinal cord injury. Biomaterials 2009, 30: 2582–2590.PubMedCrossRefGoogle Scholar
  147. [147]
    Jones LL, Oudega M, Bunge MB, Tuszynski MH. Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 2001, 533: 83–89.PubMedCrossRefGoogle Scholar
  148. [148]
    Bradbury EJ, Carter LM. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2011, 84: 306–316.PubMedCrossRefGoogle Scholar
  149. [149]
    Mountney A, Zahner MR, Lorenzini I, Oudega M, Schramm LP, Schnaar RL. Sialidase enhances recovery from spinal cord contusion injury. Proc Natl Acad Sci U S A 2010, 107: 11561–11566.PubMedCrossRefGoogle Scholar
  150. [150]
    Yang LJ, Lorenzini I, Vajn K, Mountney A, Schramm LP, Schnaar RL. Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A 2006, 103: 11057–11062.PubMedCrossRefGoogle Scholar
  151. [151]
    Mountney A, Zahner MR, Sturgill ER, Riley CJ, Aston JW, Oudega M, et al. Sialidase, chondroitinase ABC, and combination therapy after spinal cord contusion injury. J Neurotrauma 2013, 30: 181–190.PubMedCrossRefGoogle Scholar
  152. [152]
    Steinmetz MP, Horn KP, Tom VJ, Miller JH, Busch SA, Nair D, et al. Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord. J Neurosci 2005, 25: 8066–8076.PubMedCrossRefGoogle Scholar
  153. [153]
    Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416: 636–640.PubMedCrossRefGoogle Scholar
  154. [154]
    He L, Lu QR. Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci Bull 2013, 29: 129–143.PubMedCrossRefGoogle Scholar
  155. [155]
    Bregman BS, McAtee M, Dai HN, Kuhn PL. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol 1997, 148: 475–494.PubMedCrossRefGoogle Scholar
  156. [156]
    Brock JH, Rosenzweig ES, Blesch A, Moseanko R, Havton LA, Edgerton VR, et al. Local and remote growth factor effects after primate spinal cord injury. J Neurosci 2010, 30: 9728–9737.PubMedCrossRefGoogle Scholar
  157. [157]
    Novikova LN, Novikov LN, Kellerth JO. Differential effects of neurotrophins on neuronal survival and axonal regeneration after spinal cord injury in adult rats. J Comp Neurol 2002, 452: 255–263.PubMedCrossRefGoogle Scholar
  158. [158]
    Xu XM, Guenard V, Kleitman N, Aebischer P, Bunge MB. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 1995, 134: 261–272.PubMedCrossRefGoogle Scholar
  159. [159]
    Ye JH, Houle JD. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol 1997, 143: 70–81.PubMedCrossRefGoogle Scholar
  160. [160]
    Namiki J, Kojima A, Tator CH. Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats. J Neurotrauma 2000, 17: 1219–1231.PubMedCrossRefGoogle Scholar
  161. [161]
    Oudega M, Hagg T. Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord. Exp Neurol 1996, 140: 218–229.PubMedCrossRefGoogle Scholar
  162. [162]
    McTigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 1998, 18: 5354–5365.PubMedGoogle Scholar
  163. [163]
    Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 2002, 173: 46–62.PubMedCrossRefGoogle Scholar
  164. [164]
    Ritfeld GJ, Roos RA, Oudega M. Stem cells for central nervous system repair and rehabilitation. PM R 2011, 3: S117–122.PubMedCrossRefGoogle Scholar
  165. [165]
    Cooke MJ, Vulic K, Shoichet MS. Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system. Soft Matter 2010, 6: 4988–4998.CrossRefGoogle Scholar
  166. [166]
    Munoz J, Zhou Y, Jarrett HW. LG4–5 domains of laminin-211 binds alpha-dystroglycan to allow myotube attachment and prevent anoikis. J Cell Physiol 2010, 222: 111–119.PubMedCrossRefGoogle Scholar
  167. [167]
    Kim H, Cooke MJ, Shoichet MS. Creating permissive microenvironments for stem cell transplantation into the central nervous system. Trends Biotechnol 2012, 30: 55–63.PubMedCrossRefGoogle Scholar
  168. [168]
    Silva NA, Cooke MJ, Tam RY, Sousa N, Salgado AJ, Reis RL, et al. The effects of peptide modified gellan gum and olfactory ensheathing glia cells on neural stem/progenitor cell fate. Biomaterials 2012, 33: 6345–6354.PubMedCrossRefGoogle Scholar
  169. [169]
    Cooke MJ, Zahir T, Phillips SR, Shah DS, Athey D, Lakey JH, et al. Neural differentiation regulated by biomimetic surfaces presenting motifs of extracellular matrix proteins. J Biomed Mater Res A 2010, 93: 824–832.PubMedGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of BioengineeringUniversity of PittsburghPittsburghUSA
  2. 2.Department of Physical Medicine and RehabilitationUniversity of PittsburghPittsburghUSA
  3. 3.Department of NeurobiologyUniversity of PittsburghPittsburghUSA
  4. 4.Center for the Neural Basis of CognitionUniversity of PittsburghPittsburghUSA

Personalised recommendations